Provided by Sargent & Krahn
The protection of pharmaceutical products is one of the few areas where experts agree that legal protection is essential to foster innovation. Indeed, the launch of a pharmaceutical product in the market is a long and difficult process that implies the investment of enormous resources and the generation of a significant amount of necessary information to obtain the regulatory authorization to allow its commercialization, which constitutes one of the most valuable assets of a pharmaceutical company.
Also, and increasingly, the IP aspects of pharmaceutical and agro-chemical products are related to the registration process before the specialized regulatory authorities, considering the need to protect the data that the applicant must provide to obtain the authorization to sell their products. Our attorneys have experience in negotiations and regulatory litigations, and also in the management of the provisions for data protection and are thus in a unique position to advise our clients regarding these matters.
Additionally, the provisions of bioequivalence and biosimilars are becoming increasingly relevant in the process of registration and sale authorizations of pharmaceutical products, because their infringement can lead to the rejection or cancellation of said registration. The attorneys and technicians of our firm can provide the necessary guidance and advice in regulatory matters.
Sargent & Krahn fields a robust team of seasoned practitioners that are well equipped to advise on a variety of areas in the Chilean life sciences arena. The practice group demonstrates strong skills in pharmaceutical patent prosecutions and opposition mandates. The Santiago-based law firm regularly offers advice on legal and administrative regulatory changes to both Chilean and international clients.
"When handling a complex patent prosecution matter for us, Sargent & Krahn are client-focused and well staffed."
Sargent & Krahn's life sciences team represented multinational agrochemical company Dow AgroSciences before the Chilean court in a patent prosecution procedure in which the legal team fulfilled the inventive step requirement and handled all other patentability requirements.
Juan Pablo Egaña is praised by market commentators for his practice representing pharmaceutical clients in a host of patent disputes in the Chilean life sciences sector. One client notes: "Juan Pablo Egaña is an extremely well-rounded lawyer, with extensive life sciences knowledge and impeccable analytical skills. He is highly available and committed, and is able to handle complex mandates."
Up-and-coming life sciences partner Cristián Barros frequently represents global pharmaceutical companies in regulatory and patent issues in Chile. Clients state: "Cristián Barros is a superb lawyer, with in-depth knowledge of life science matters. His advice is very valuable for our organisation and he always meets our requirements."